Menu

Events & Webinars

Recognizing Safety Risks and Taking Action to Maximize the Benefits of Smart Pump Technology

 
A midday symposium conducted at the 2017 ASHP Midyear Clinical Meeting and Exhibition

Monday, December 4, 2017 - 11:30am-1:00pm ET
Room W102, Level 1 – Orange County Convention Center-West Concourse

 

Register to attend in Orlando
 

Overview

Healthcare organizations often do not use smart infusion pump technology to its full potential, which sometimes results in serious intravenous medication errors and associated patient harm. As such, it is important to optimize the safety benefits of smart pumps while ensuring readiness for integration with other available technologies, such as computerized prescriber order entry (CPOE) systems and electronic health records (EHRs). This symposium will address current safety issues due to smart pump underutilization, the implementation of a comprehensive drug library to promote compliance, methods to analyze pump data to investigate the use of best practices, and the steps pharmacists can take now in preparation for future technology interoperability.

Objectives

The target audience for this activity includes pharmacists and pharmacy technicians in health-system settings. At the completion of this symposium, the participant will be able to:

  • Summarize the scope of intravenous infusion errors that continue to occur despite the inherent safety benefits of smart infusion pumps.
  • Identify key concepts necessary for building a comprehensive drug library and driving user compliance.
  • Explain how organizations actively manage smart pump data to increase patient safety through improved drug library use and associated clinical practice.
  • Describe the components and advantages of using a standardized drug library for multi-hospital health systems to improve patient safety and workflow efficiency.
  • Articulate the elements necessary for successful standardization of products, drug concentrations, dosing nomenclature, parameters, and components of infusion orders in advance of smart pump implementation.

Agenda

10:45am - Doors open
11:30am-1:00pm - Symposium
 
Space is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis.

Food and beverages are not provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session.

Topics and Faculty

Smart Pump Technology: Recognizing the Gains and Addressing the Gaps
Michelle Mandrack, MSN, RN
Director of Consulting Services, ISMP

Managing the Smart Pump Drug Library as a Key Driver of IV Medication Safety
Dennis Killian, PhD, PharmD
Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD

Successful Implementation of Smart Pump Technology with a Standardized Drug Library in a Multi-Hospital Health System
Cecilia Sawatari, PharmD
Pharmacy Manager, Baptist Hospital of Miami, Miami, FL

CE Accreditation

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-411-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 4, 2017). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 5, 2018 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

Funding

This symposium is funded through an educational grant from Baxter Healthcare Corporation.

    

Register to attend in Orlando
 

Institute for Safe Medication Practices (ISMP)
200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797 www.ismp.org